Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice

David M.G. Halpin, Sally Worsley, Afisi S. Ismaila, Kai-Michael Beeh, Dawn Midwinter, Janwillem W.H. Kocks, Elaine Irving, Jose M. Marin, Neil Martin, Maggie Tabberer, Neil G. Snowise, Chris Compton
ERJ Open Research 2021 7: 00950-2020; DOI: 10.1183/23120541.00950-2020
David M.G. Halpin
1University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: d.halpin@nhs.net
Sally Worsley
2GSK R&D, Stevenage, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Afisi S. Ismaila
3Value Evidence and Outcomes, GSK, Collegeville, PA, USA
4Dept of Health Research Methods Evidence and Impact, McMaster University, Hamilton, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kai-Michael Beeh
5Insaf Respiratory Research Institute, Wiesbaden, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dawn Midwinter
6GSK R&D, Brentford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janwillem W.H. Kocks
7General Practitioners Research Institute, Groningen, The Netherlands
8University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, The Netherlands
9Observational and Pragmatic Research Institute, Singapore
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaine Irving
2GSK R&D, Stevenage, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose M. Marin
10University Hospital Miguel Servet, IIS Aragón and CIBERES, Zaragoza, Spain
11CIBER Enfermedades Respiratorias, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jose M. Marin
Neil Martin
12Global Medical Affairs, GSK, Brentford, UK
13Institute for Lung Health, University of Leicester, Leicester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maggie Tabberer
14Value Evidence and Outcomes, GSK, Brentford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil G. Snowise
12Global Medical Affairs, GSK, Brentford, UK
15Faculty of Life Sciences and Medicine, King's College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chris Compton
16Global Respiratory Franchise, GSK, Brentford, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 7 no. 2
DOI 
https://doi.org/10.1183/23120541.00950-2020

Published By 
European Respiratory Society
Online ISSN 
2312-0541
History 
  • Received December 17, 2020
  • Accepted March 23, 2021
  • Published online June 7, 2021.

Article Versions

  • previous version (April 22, 2021 - 06:41).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright ©The authors 2021 This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions@ersnet.org

Author Information

  1. David M.G. Halpin1⇑,
  2. Sally Worsley2,
  3. Afisi S. Ismaila3,4,
  4. Kai-Michael Beeh5,
  5. Dawn Midwinter6,
  6. Janwillem W.H. Kocks7,8,9,
  7. Elaine Irving2,
  8. Jose M. Marin10,11,
  9. Neil Martin12,13,
  10. Maggie Tabberer14,
  11. Neil G. Snowise12,15 and
  12. Chris Compton16
  1. 1University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, UK
  2. 2GSK R&D, Stevenage, UK
  3. 3Value Evidence and Outcomes, GSK, Collegeville, PA, USA
  4. 4Dept of Health Research Methods Evidence and Impact, McMaster University, Hamilton, ON, Canada
  5. 5Insaf Respiratory Research Institute, Wiesbaden, Germany
  6. 6GSK R&D, Brentford, UK
  7. 7General Practitioners Research Institute, Groningen, The Netherlands
  8. 8University of Groningen, University Medical Center Groningen, GRIAC Research Institute, Groningen, The Netherlands
  9. 9Observational and Pragmatic Research Institute, Singapore
  10. 10University Hospital Miguel Servet, IIS Aragón and CIBERES, Zaragoza, Spain
  11. 11CIBER Enfermedades Respiratorias, Madrid, Spain
  12. 12Global Medical Affairs, GSK, Brentford, UK
  13. 13Institute for Lung Health, University of Leicester, Leicester, UK
  14. 14Value Evidence and Outcomes, GSK, Brentford, UK
  15. 15Faculty of Life Sciences and Medicine, King's College London, London, UK
  16. 16Global Respiratory Franchise, GSK, Brentford, UK
  1. David M.G. Halpin, University of Exeter Medical School, College of Medicine and Health, University of Exeter, Exeter, EX1 2LU, UK. E-mail: d.halpin{at}nhs.net
View Full Text

Funding

  • GlaxoSmithKline

    GSK study number CTT206854; NCT03467425

Article usage

Article usage: April 2021 to December 2022

AbstractFullPdf
Apr 202147369148
May 202188687433
Jun 202127820493
Jul 202123500209
Aug 202111481173
Sep 202117410207
Oct 20219466213
Nov 20219483187
Dec 202110375114
Jan 20225367116
Feb 202220469139
Mar 20222524167
Apr 202210361135
May 20227400140
Jun 202210372128
Jul 202222520108
Aug 202210416130
Sep 202211384108
Oct 202219443115
Nov 20222636498
Dec 2022719449

Altmetrics

PreviousNext
Back to top
Vol 7 Issue 2 Table of Contents
ERJ Open Research: 7 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
David M.G. Halpin, Sally Worsley, Afisi S. Ismaila, Kai-Michael Beeh, Dawn Midwinter, Janwillem W.H. Kocks, Elaine Irving, Jose M. Marin, Neil Martin, Maggie Tabberer, Neil G. Snowise, Chris Compton
ERJ Open Research Apr 2021, 7 (2) 00950-2020; DOI: 10.1183/23120541.00950-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice
David M.G. Halpin, Sally Worsley, Afisi S. Ismaila, Kai-Michael Beeh, Dawn Midwinter, Janwillem W.H. Kocks, Elaine Irving, Jose M. Marin, Neil Martin, Maggie Tabberer, Neil G. Snowise, Chris Compton
ERJ Open Research Apr 2021, 7 (2) 00950-2020; DOI: 10.1183/23120541.00950-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Abstract
    • Introduction
    • Materials and methods
    • Results
    • Discussion
    • Supplementary material
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • COPD and smoking
  • Pulmonary pharmacology and therapeutics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Original articles

  • Endobronchial autologous BM-MSCs in IPF patients
  • Effect of β-blockers on the risk of COPD exacerbations
  • Recurrence of symptoms after childhood LRTI
Show more Original articles

COPD

  • Admissions following first exacerbation-related hospitalisation
  • Improving the wellbeing of caregivers of patients with COPD
  • Arterial remodelling in smokers, and patients with small airway disease and COPD
Show more COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society